Literature DB >> 26557515

Methicillin Resistant Staphylococcus aureus: Inconsistencies in Vancomycin Susceptibility Testing Methods, Limitations and Advantages of each Method.

Charu Agrawal1, Molly Madan2, Anita Pandey3, Bhaskar Thakuria4.   

Abstract

BACKGROUND: Vancomycin may be ineffective against an increasing proportion of methicillin resistant Staphylococcus aureus (MRSA) with minimum inhibitory concentrations (MICs) well within the susceptible range. On the other hand it is common knowledge that determination of vancomycin MICs is method dependent. Therefore, given the apparent variability in vancomycin MIC results obtained with the different methods, the use of the vancomycin MIC to predict the outcome of serious S. aureus infections needs to take into account the method used and the results of studies using that particular method. AIM: Comparative study was carried out to evaluate the MICs obtained by BMD method, E-test, and Vitek 2 method and to detect inconsistencies in these vancomycin for 66 MRSA isolates obtained from various samples of patients attending the OPDs & IPDs within a period of one year.
MATERIALS AND METHODS: A comparative study was carried out to evaluate the MICs obtained by BMD method, E-test, and Vitek 2 method to detect vancomycin susceptibility in 66 clinical isolates of MRSA obtained from various samples of patients attending the OPDs & IPDs within a period of one year. The study was conducted in Department of Microbiology, Subharti Medical College, Meerut from January to December 2012.
RESULTS: On determination of MICs for vancomycin for the MRSA isolates, all were identified as VSSA by BMD, E-Test & Vitek 2 methods. However, the vancomycin MIC values obtained by E-test correlated better with BMD method (correlation factor= 0.6727) than Vitek 2 (correlation factor=0.5316), indicating E-Test to be a better method for determination of vancomycin MICs as compared to Vitek 2.
CONCLUSION: MRSA isolates with higher vancomycin MICs, even within the susceptibility range, are being observed more frequently which result in treatment failures with vancomycin. Because of the discrepancy that exists in vancomycin MIC results from different methods, the prediction of outcome of serious S.aureus infections should take into account the method used & results of studies using that particular method.

Entities:  

Keywords:  BMD; E-Test; MRSA; Minimum inhibitory concentration; Vitek 2

Year:  2015        PMID: 26557515      PMCID: PMC4625234          DOI: 10.7860/JCDR/2015/10072.6625

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

Review 1.  Serious infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Helen Boucher; Loren G Miller; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

2.  Micrococcus Poisoning.

Authors:  A Ogston
Journal:  J Anat Physiol       Date:  1882-10

3.  Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.

Authors:  Bijayini Behera; Purva Mathur
Journal:  Jpn J Infect Dis       Date:  2009-07       Impact factor: 1.362

4.  Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.

Authors:  Michael J Rybak; Celine Vidaillac; Helio S Sader; Paul R Rhomberg; Hossein Salimnia; Lawrence E Briski; Audrey Wanger; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

5.  Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Authors:  Donald I Hsu; Levita K Hidayat; Ryan Quist; Janet Hindler; Asa Karlsson; Anne Yusof; Annie Wong-Beringer
Journal:  Int J Antimicrob Agents       Date:  2008-08-12       Impact factor: 5.283

6.  Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

Authors:  Helio S Sader; Paul R Rhomberg; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

7.  Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Authors:  T P Lodise; J Graves; A Evans; E Graffunder; M Helmecke; B M Lomaestro; K Stellrecht
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

8.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 9.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.

Authors:  Abhay Dhand; George Sakoulas
Journal:  F1000 Med Rep       Date:  2012-02-01
View more
  1 in total

1.  Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Authors:  Mark Wilcox; Suleiman Al-Obeid; Ana Gales; Roman Kozlov; José A Martínez-Orozco; Flavia Rossi; Sergey Sidorenko; Joseph Blondeau
Journal:  Future Microbiol       Date:  2019-02-06       Impact factor: 3.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.